<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joy D Howell, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gregory Redding, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Adrienne G Randolph, MD, MSc
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 18, 2018.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H344201848">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma is the most frequent cause of hospitalization among children in the United States and, as of 1999, was the source of nearly 500,000 admissions per year to pediatric intensive care units (PICUs) [
         <a href="#rid1">
          1
         </a>
         ]. Asthma prevalence continues to rise. However, mortality rates in children and adults have begun to fall since 1999 [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Endotracheal intubation and mechanical ventilation of children with acute severe asthma exacerbation (ie, status asthmaticus) are discussed here. General intensive care unit (ICU) management, primarily pharmacotherapy, and non-ICU inpatient management are discussed in greater detail separately. Mechanical ventilation for adults with severe asthma is also reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5748.html" rel="external">
          "Acute asthma exacerbations in children younger than 12 years: Inpatient management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/570.html" rel="external">
          "Invasive mechanical ventilation in adults with acute exacerbations of asthma"
         </a>
         .)
        </p>
        <p>
         Pharmacologic management of acute asthma exacerbations and management of chronic childhood asthma also are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">
          "Acute asthma exacerbations in children younger than 12 years: Emergency department management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5742.html" rel="external">
          "Asthma in children younger than 12 years: Initial evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5744.html" rel="external">
          "Asthma in children younger than 12 years: Management of persistent asthma with controller therapies"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5743.html" rel="external">
          "Asthma in children younger than 12 years: Quick-relief (rescue) treatment for acute symptoms"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344202056">
         <span class="h1">
          GENERAL PRINCIPLES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with acute severe asthma who fail to improve with initial treatment in the emergency department should be admitted to the pediatric intensive care unit (PICU). Intensive care unit (ICU)-level management of these children entails the administration of glucocorticoids, aggressive bronchodilator therapy, and close monitoring [
         <a href="#rid3">
          3
         </a>
         ]. Use of noninvasive positive pressure ventilation (NPPV) may help avoid the need for intubation in many patients who progress toward respiratory muscle fatigue by reducing the work of breathing until maximal therapeutic effects of pharmacotherapy take place. Earlier use in the emergency department, rather than waiting until admission to the PICU, is increasing as familiarly with this modality grows [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Pharmacotherapy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Noninvasive positive pressure ventilation'
         </a>
         .)
        </p>
        <p>
         Mechanical ventilation is reserved for patients with continued progression toward respiratory failure despite maximal medical therapy. The use of mechanical ventilation during an asthma exacerbation has associated morbidities, but mortality due to complications that occurred after ICU admission is uncommon [
         <a href="#rid5">
          5-9
         </a>
         ]. Within PICUs, mechanical ventilation rates for children with asthma vary from center to center, with published rates ranging from &lt;1 percent to 10 to 20 percent [
         <a href="#rid5">
          5,6,8
         </a>
         ]. (See
         <a class="local">
          'Endotracheal intubation and mechanical ventilation'
         </a>
         below and
         <a class="local">
          'Outcomes'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Prognosis'
         </a>
         .)
        </p>
        <p>
         The need for mechanical respiratory support and potential invasive ventilation should be considered early in the course of illness. The best way to avoid intubation is to rapidly escalate the preintubation therapies in patients with a worsening trajectory indicated by increased work of breathing or carbon dioxide (CO
         <sub>
          2
         </sub>
         ) retention. Several reports have shown that children intubated prior to ICU care are on mechanical ventilation for a shorter duration, most likely because the patients were intubated prior to intensive delivery of bronchodilators and glucocorticoids [
         <a href="#rid6">
          6,8,10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Preintubation therapies'
         </a>
         .)
        </p>
        <p>
         Mechanical ventilation in a child with an asthma exacerbation is always challenging due to airway obstruction, impaired exhalation, and risk of barotrauma. The decision to intubate a patient to prevent severe hypoxia should be made with great care since tracheal stimulation can worsen the asthma exacerbation and frequently worsens airway obstruction and hypercarbia. (See
         <a class="local">
          'Complications'
         </a>
         below.)
        </p>
        <p>
         Adjunctive therapies may be necessary for children who do not improve despite aggressive pharmacologic therapy and mechanical ventilation. (See
         <a class="local">
          'Adjunctive therapies'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344202293">
         <span class="h1">
          SUPPORTIVE CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children admitted to the intensive care unit (ICU) with severe asthma require close cardiopulmonary monitoring, particularly those on mechanical ventilation. Supportive measures for children with asthma who require mechanical ventilation include analgesia, sedation, and potentially also muscle relaxation if a spontaneous breathing mode is not used [
         <a href="#rid6">
          6,11-13
         </a>
         ]. These supportive measures help to prevent breath stacking and ventilator dyssynchrony, which can aggravate hypercapnia. Most patients are also given intravenous fluids to treat dehydration and prevent hypotension. Sedation and paralysis are reviewed below. Other supportive measures are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Supportive care'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344202400">
         <span class="h2">
          Sedation and paralysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of agents can be used for sedation for the patient with asthma who requires intubation and mechanical ventilation. The sedative agents that can be used for intubation include
         <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">
          fentanyl
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">
          midazolam
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12907" href="/z/d/drug information/12907.html" rel="external">
          etomidate
         </a>
         .
         <a class="drug drug_pediatric" data-topicid="16024" href="/z/d/drug information/16024.html" rel="external">
          Morphine
         </a>
         may generate histamine release and therefore is generally avoided. Additionally, neuromuscular blocking agents may be used to optimize intubating conditions. Once patients are intubated, sedation is also used to promote patient/ventilator synchrony and blunt tachypnea in order to reduce the risk of air trapping and barotrauma.
        </p>
        <p>
         Of the sedative agents that are available to facilitate intubation,
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         is most commonly used. Ketamine, a synthetic derivative of phencyclidine, is often recommended as the induction agent of choice for the asthma patient requiring intubation because it has bronchodilatory as well as sedative effects. Ketamine also has been administered as a continuous infusion in patients receiving invasive or noninvasive positive pressure ventilation (NPPV) for asthma [
         <a href="#rid14">
          14
         </a>
         ]. When used in this fashion, a loading dose of 2 mg/kg is followed by an infusion of 20 to 60 micrograms/kg/min [
         <a href="#rid3">
          3
         </a>
         ]. The evidence in support of use of ketamine in children is limited. In one study, improvements were seen in the partial pressure of oxygen in arterial blood to the fraction of inspired oxygen (PaO
         <sub>
          2
         </sub>
         /FiO
         <sub>
          2
         </sub>
         ) ratio in all patients studied, and dynamic compliance, partial pressure of carbon dioxide (pCO
         <sub>
          2
         </sub>
         ), and peak inspiratory pressures (PIP) improved in those mechanically ventilated [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/113029.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis", section on 'Sedation (induction) agents'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          Propofol
         </a>
         is another agent that is used to facilitate intubation in children. It is a potent hypnotic/anesthetic agent that accomplishes global central nervous system depression via activation of gamma-aminobutyric acid (GABA) receptors. Propofol decreases the cerebral metabolic rate for oxygen consumption and reduces intracranial pressure. In addition, it is reported to have anti-inflammatory properties and to dilate central airways. For this reason, it is commonly used to facilitate intubation in patients with status asthmaticus [
         <a href="#rid15">
          15
         </a>
         ]. There are documented reports of propofol-induced bronchoconstriction in some patients with atopy and drug-induced asthma but bronchodilation in others [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         Unlike
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         , for which there is no prohibition against prolonged use in the pediatric intensive care unit (PICU), prolonged use of
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         (&gt;48 hours) is associated with propofol infusion syndrome that includes cardiac and renal failure, rhabdomyolysis, hepatomegaly, hyperkalemia, hypertriglyceridemia, and metabolic acidosis [
         <a href="#rid16">
          16-18
         </a>
         ]. It occurs more commonly in children and in critically ill patients treated with glucocorticoids and catecholamines and is not recommended for continuous sedation in the PICU by the US Food and Drug Administration (FDA) [
         <a href="#rid19">
          19-21
         </a>
         ]. Nonetheless, there are numerous studies that have demonstrated the safe use of propofol for sedation in over 500 PICU patients, suggesting that propofol can be at doses &lt;4 mg/kg/hour for under 48 hours in this population [
         <a href="#rid22">
          22-24
         </a>
         ].
        </p>
        <p>
         A broad range of medications are also available for maintenance of sedation in intubated pediatric patients with asthma.
         <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">
          Fentanyl
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="12611" href="/z/d/drug information/12611.html" rel="external">
          midazolam
         </a>
         in combination are commonly used in the PICU setting to accomplish sedation [
         <a href="#rid25">
          25
         </a>
         ].
         <a class="drug drug_pediatric" data-topicid="13128" href="/z/d/drug information/13128.html" rel="external">
          Dexmedetomidine
         </a>
         , a selective alpha-2-receptor agonist, is approved for use for up to 24 hours in the adult population. There are multiple reports of its safety and efficacy in the pediatric population [
         <a href="#rid26">
          26
         </a>
         ]. Dosing is largely extrapolated from the adult literature. Patients are typically loaded with 0.5 to 1 mcg/kg over 10 to 20 minutes, but some pediatric centers reduce or eliminate the loading dose in an effort to avoid hypotension and bradycardia, the two most commonly encountered adverse effects in the pediatric population. The available literature espouses an infusion dose range from 0.2 to 0.7 mcg/kg/hour. The pediatric literature suggests that infusions can be safely given beyond the recommended limit of 24 hours and at doses as high as 2 mcg/kg/hour. In addition to sedation for the ventilated patient, dexmedetomidine is also used to facilitate tolerance of NPPV [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Neuromuscular blockade may be employed as an adjunct to intubation and to blunt tachypnea and ventilator dyssynchrony in sedated patients receiving assisted ventilation [
         <a href="#rid11">
          11
         </a>
         ]. However, efforts should be made to discontinue the use of neuromuscular blocking agents as soon as is feasible since their use in combination with glucocorticoids is associated with an increased risk of myopathy of critical illness [
         <a href="#rid5">
          5,28-34
         </a>
         ]. In addition, pressure support cannot be used in a paralyzed patient. Spontaneous breathing modes of mechanical ventilation are generally more comfortable and use substantially lower peak airway pressures. (See
         <a class="local">
          'Pressure support'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/113029.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis", section on 'Paralytic agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344203926">
         <span class="h1">
          ENDOTRACHEAL INTUBATION AND MECHANICAL VENTILATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intubation should be approached cautiously in patients with status asthmaticus because manipulation of the airway can cause increased airflow obstruction due to exaggerated bronchial responsiveness. Adequate venous access, frequent noninvasive blood pressure monitoring, and sedation should be optimized before intubation. The clinician most experienced with airway management should perform the intubation. (See
         <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">
          "Technique of emergency endotracheal intubation in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Approach"
         </a>
         .)
        </p>
        <p>
         Clinicians must be prepared to manage acute deterioration due to tube malposition, tube obstruction, pneumothorax, equipment failure, and/or hypotension [
         <a href="#rid35">
          35
         </a>
         ]. (See
         <a class="local">
          'Complications'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344204005">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         The decision to intubate a patient with status asthmaticus is made based upon clinical findings (eg, inability to speak, confusion or somnolence, hypoxia despite supplemental oxygen) and physiologic changes (eg, moderate-to-severe hypercapnia). Care must be taken to control the airway before the patient suffers a respiratory arrest or a hypoxic insult. (See
         <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">
          "Technique of emergency endotracheal intubation in children"
         </a>
         .)
        </p>
        <p>
         Indications for intubation in patients with acute severe asthma include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoxemia despite provision of high concentrations of oxygen or noninvasive positive pressure ventilation (NPPV; partial pressure of oxygen [pO
         <sub>
          2
         </sub>
         ] &lt;60 on 100 percent oxygen or NPPV)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe and unremitting increased work of breathing (eg, inability to speak)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered mental status
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory or cardiac arrest
        </p>
        <p>
        </p>
        <p>
         Hypercarbia alone is not an indication for intubation [
         <a href="#rid5">
          5,36,37
         </a>
         ]. However, intubation is warranted if a patient demonstrates a progressively rising arterial partial pressure of carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) despite maximal medical therapy and/or NPPV and if hypercarbia is causing significant respiratory acidosis or altered mental status.
        </p>
        <p class="headingAnchor" id="H344204065">
         <span class="h2">
          Goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goals of endotracheal intubation and mechanical ventilation for children with status asthmaticus and respiratory failure are [
         <a href="#rid38">
          38
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To relieve work of breathing from the exhausted patient and allow respiratory muscle rest
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To ensure adequate oxygenation (see
         <a class="local">
          'Oxygenation'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To ensure sufficient (not necessarily normal) gas exchange (initial hypercarbia is tolerated) until airway obstruction can be reversed (see
         <a class="local">
          'Ventilation strategy'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         These goals should be accomplished with the fewest adverse effects. The patient should be given breaths with a bag and in-line manometer prior to initiating mechanical ventilation. Careful noting of the number of seconds needed for expiration to finish is important to avoid breath stacking, auto-positive end-expiratory pressure (PEEP), and the resultant increased end-expiratory and inspiratory lung volumes that increase alveolar pressure, the risk of barotrauma, and may compromise cardiac function by increasing pulmonary vascular resistance. The respiratory rate (RR) on the ventilator should be sufficiently low to permit a normal inspiratory time and a generous expiratory time. (See
         <a class="local">
          'Complications'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344204115">
         <span class="h3">
          Oxygenation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adequate oxygenation is usually achieved without difficulty in most patients with asthma since the airways, not the alveoli, are the primary targets of inflammation and bronchospasm. However, mucus plugging, atelectasis, hyperinflation, and ventilation/perfusion (V/Q) mismatch may contribute to hypoxemia. In mechanically ventilated patients, oxygenation is affected primarily by the fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) and mean airway pressure. (See
         <a class="local">
          'Ventilator settings'
         </a>
         below.)
        </p>
        <p>
         Atelectasis that results from mucus plugging can usually be treated with judicious application of PEEP, as well as regular removal of secretions from the endotracheal tube [
         <a href="#rid39">
          39
         </a>
         ]. In addition, positioning of the patient so that collapsed lung segments are nondependent helps to improve atelectasis.
        </p>
        <p>
         If these measures prove insufficient, extrinsic PEEP above initial PEEP (3 to 5 cm H
         <sub>
          2
         </sub>
         O is suggested) may be carefully applied. The careful titration of PEEP may help recruit atelectatic lung units. Hyperinflation, however, by generating more zone I physiology (where alveolar pressure exceeds pulmonary arterial pressure), may produce V/Q mismatch and therefore worsen hypoxemia. (See
         <a class="local">
          'Ventilator settings'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H14579420">
         <span class="h2">
          Ventilation strategy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Successful mechanical ventilation in patients with asthma depends upon limiting the risk of hyperinflation and barotrauma. The risk of hyperinflation is reduced by decreasing the minute volume and permitting adequate time for complete exhalation before the next inhalation begins. Dropping the RR while maintaining a normal (constant) inspiratory time increases the expiratory time, thereby decreasing the ratio of inspiratory to expiratory time (I:E ratio) [
         <a href="#rid11">
          11
         </a>
         ]. The risk of barotrauma is decreased by minimizing hyperinflation and peak inspiratory pressures (PIP). For these reasons, many consider pressure support ventilation (PSV) the ideal mode of ventilation for the intubated patient with asthma. However, pressure control and volume control may also be used. There is no evidence to support one mode of ventilation over another. (See
         <a class="local">
          'Ventilator settings'
         </a>
         below and
         <a class="local">
          'Dynamic hyperinflation'
         </a>
         below and
         <a class="local">
          'Barotrauma'
         </a>
         below.)
        </p>
        <p>
         Diminishing the risk of hyperinflation and barotrauma requires acceptance of an initial PaCO
         <sub>
          2
         </sub>
         that is higher than normal with an accompanying respiratory acidosis, a strategy that is called "permissive hypercapnia" or "controlled hypoventilation" [
         <a href="#rid40">
          40,41
         </a>
         ]. A slow increase in PaC0
         <sub>
          2
         </sub>
         (approximately 10 mmHg/hour) permits intracellular buffering mechanisms to accommodate the decreasing serum pH [
         <a href="#rid12">
          12
         </a>
         ]. This strategy is widely used in patients with asthma [
         <a href="#rid40">
          40,42-44
         </a>
         ]. Permissive hypercarbia is well tolerated by children with normal cardiac function. However, those with concurrent chronic conditions, such as cyanotic heart disease, cardiomyopathy, or pulmonary hypertension, will probably not tolerate this strategy. Other potential contraindications to permissive hypercapnic ventilation include increased intracranial pressure, poor myocardial function, and coexistent metabolic acidosis (eg, patients with renal disease).
        </p>
        <p class="headingAnchor" id="H344204187">
         <span class="h2">
          Ventilatory modes
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of ventilatory modes have been successfully employed in the management of patients with asthma who require intubation [
         <a href="#rid11">
          11,45
         </a>
         ]. These include pressure control ventilation (PCV), pressure support ventilation (PSV), volume control ventilation (eg, pressure-regulated volume control [PRVC]), and synchronized intermittent mandatory ventilation (SIMV), which is delivered with pressure control (SIMV/PC) or volume control (SIMV/VC).
        </p>
        <p>
         Volume control ventilation (eg, PRVC or SIMV/VC) allows for consistent minute ventilation (RR x tidal volume [TV]) in the face of changing airway resistance and lung compliance. PRVC assures that the patient receives the desired/set TV at the lowest peak pressure possible [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344204249">
         <span class="h3">
          Volume control
         </span>
         <span class="headingEndMark">
          —
         </span>
         In volume control ventilation (PRVC or SIMV/VC), inspiration is terminated after delivery of a preset TV. An advantage to volume control ventilation is that it permits comparison of PIP and plateau pressure (Pplat) measurements (peak-to-plateau measurements), which provides an indication of airway resistance and response to therapy [
         <a href="#rid11">
          11
         </a>
         ]. A disadvantage is that peak pressures may be elevated, depending upon airway resistance, mucus plugging, and the degree of atelectasis. Volume control is an acceptable mode of mechanical ventilation and is preferred by some. However, the patient may need to be transitioned to PRVC and/or paralyzed if the PIP or Pplat rise above 35 cm or 30 H
         <sub>
          2
         </sub>
         O, respectively, with the caveat that use of neuromuscular blockade should be kept to a minimum in an effort to avoid myopathy of critical illness.
        </p>
        <p class="headingAnchor" id="H344204269">
         <span class="h4">
          Pressure-regulated volume control
         </span>
         <span class="headingEndMark">
          —
         </span>
         PRVC is a mode specific to the Servo 300 and Servo I ventilators (the latter has SIMV/PRVC) that assures the patient receives the desired/set TV but at the lowest peak pressure possible. PRVC offers advantages of both volume and PCV. These include optimal decelerating inspiratory flow, assured TV, and minimized airway pressures [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344204289">
         <span class="h3">
          Pressure control
         </span>
         <span class="headingEndMark">
          —
         </span>
         In pressure control ventilation (SIMV/PC), inspiration ceases when a preset maximum pressure is reached. The delivered volume varies depending upon lung mechanics (eg, airway resistance, lung compliance, hyperinflation), and minute ventilation is not assured.
        </p>
        <p class="headingAnchor" id="H344204295">
         <span class="h3">
          Pressure support
         </span>
         <span class="headingEndMark">
          —
         </span>
         PSV is flow cycled in that, once triggered by a demand valve, the preset pressure is sustained until the inspiratory flow tapers, usually to 25 percent of its maximal value [
         <a href="#rid46">
          46
         </a>
         ]. The clinician determines the final airway pressure with PSV. TV and RR (ie, minute volume) are a consequence of patient-related variables plus ventilator settings. Increasing levels of PSV can be used to decrease patient effort early in the course of mechanical ventilation [
         <a href="#rid13">
          13
         </a>
         ]. PSV decreases patient-ventilatory dyssynchrony and is useful when weaning from ventilatory support [
         <a href="#rid5">
          5
         </a>
         ]. Functionally, PSV (invasive) is equivalent to bilevel positive airway pressure (BiPAP; noninvasive). As with PCV, minute ventilation is not assured. (See
         <a class="local">
          'Weaning from mechanical ventilation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344204367">
         <span class="h3">
          Synchronized intermittent mandatory ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         In SIMV, the ventilator delivers breaths based upon a preset TV or peak pressure and RR that are synchronized with the patient's inspiratory effort. However, if the patient fails to initiate a breath, a full TV breath will be delivered at the appropriate interval (ie, one breath every five seconds if the RR is set at 12 breaths per minute). SIMV can be delivered with volume control (SIMV/VC) or pressure control (SIMV/PC). Volume control is preferred at the author's institution. SIMV/VC along with PSV is useful when weaning from ventilatory support. (See
         <a class="local">
          'Weaning from mechanical ventilation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344204773">
         <span class="h2">
          Ventilator settings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice of mechanical ventilator settings must take into account the physiologic derangements of acute severe asthma, including airflow obstruction and atelectasis [
         <a href="#rid11">
          11
         </a>
         ], as well as the objectives of minimizing hyperinflation and barotrauma.
        </p>
        <p>
         Initial ventilator settings are adjusted as necessary to maintain adequate ventilation, as assessed by chest auscultation and measurement of arterial blood gases  (
         <a class="graphic graphic_table graphicRef77503" href="/z/d/graphic/77503.html" rel="external">
          table 1
         </a>
         ), and to prevent complications. The placement of an indwelling arterial catheter facilitates obtaining frequent arterial blood samples and continuous arterial pressure monitoring; however, many children who are intubated prior to intensive care unit (ICU) admission are intubated for a day or less and frequently may not require invasive vascular pressure monitors [
         <a href="#rid6">
          6,8,10,47
         </a>
         ]. This is likely because the patients were intubated prior to intensive delivery of bronchodilators and glucocorticoids. (See
         <a class="local">
          'Ventilation strategy'
         </a>
         above and
         <a class="local">
          'Complications'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Monitoring'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6327.html" rel="external">
          "Arterial puncture and cannulation in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344204971">
         <span class="h3">
          Fraction of inspired oxygen (FiO2)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) should be set at 1.0 upon intubation. FiO
         <sub>
          2
         </sub>
         is then decreased as tolerated to concentrations of 0.5 or lower to maintain oxygen saturation &gt;92 percent [
         <a href="#rid12">
          12
         </a>
         ]. Use of an FiO
         <sub>
          2
         </sub>
         of 1.0 for prolonged periods in patients with asthma predisposes them to resorption atelectasis and should therefore be avoided.
        </p>
        <p class="headingAnchor" id="H344204991">
         <span class="h3">
          Respiratory rate
         </span>
         <span class="headingEndMark">
          —
         </span>
         The RR should be set near or below physiologic rates (8 to 12 breaths per minute) [
         <a href="#rid40">
          40
         </a>
         ], keeping the minute ventilation under 115 mL/kg per minute. (See
         <a class="medical medical_review" href="/z/d/html/570.html" rel="external">
          "Invasive mechanical ventilation in adults with acute exacerbations of asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344205035">
         <span class="h3">
          Tidal volume
         </span>
         <span class="headingEndMark">
          —
         </span>
         The delivered TV should initially be 6 to 8 mL/kg [
         <a href="#rid12">
          12
         </a>
         ]. The peak and Pplat attained with these volumes should be noted and kept under 40 cm H
         <sub>
          2
         </sub>
         O and 30 to 35 cm H
         <sub>
          2
         </sub>
         O, respectively. Maintaining these limits helps to minimize dynamic hyperinflation and barotrauma [
         <a href="#rid12">
          12
         </a>
         ]. The TV may need to be reduced if the peak pressure limit exceeds 40 cm H
         <sub>
          2
         </sub>
         O [
         <a href="#rid11">
          11
         </a>
         ]. Reducing the TV will result in increased PaCO
         <sub>
          2
         </sub>
         . (See
         <a class="local">
          'Dynamic hyperinflation'
         </a>
         below and
         <a class="local">
          'Barotrauma'
         </a>
         below and
         <a class="local">
          'Ventilation strategy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H344205162">
         <span class="h3">
          Inspiratory and expiratory times and inspiratory flow
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inspiratory times should be normal to slightly low for patient age (0.75 to 1.2 seconds) and the RR sufficiently low so that the expiratory time prevents breath stacking. Thus, the cycle time is six seconds if the RR is 10, and the I:E ratio is 1:5 if the inspiratory time is one second.
        </p>
        <p>
         Expiratory time should be maximized to allow complete exhalation, avoid hypercarbia, and prevent dynamic hyperinflation and intrinsic PEEP (elevation of alveolar pressure above atmospheric pressure or set PEEP at the end of exhalation, also called auto-PEEP).
        </p>
        <p>
         To this end, inspiratory flow should be set at the highest rate the patient can tolerate without generating excessively high peak pressures. Flow rates of 4 to 10 L/kg per minute, with a maximum of 80 to 100 L/minute, are typically employed in children during PCV [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344205182">
         <span class="h3">
          Positive end-expiratory pressure (PEEP)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some degree of extrinsic PEEP is necessary to compensate for the external resistance added to the respiratory tract by the endotracheal tube (eg, PEEP of 3 to 5 cm H
         <sub>
          2
         </sub>
         O). The use of extrinsic PEEP beyond this amount in the ventilated patient with asthma is considered controversial by some [
         <a href="#rid11">
          11,12,49,50
         </a>
         ]. However, other experts feel that PEEP is a helpful intervention with proper precautions, particularly in patients with atelectasis, since PEEP can effectively stent open collapsed airways, improve ventilation, and potentially reduce air trapping [
         <a href="#rid49">
          49
         </a>
         ]. Application of low levels of PEEP also may relieve dyspnea by facilitation of ventilator triggering and synchronization for intubated patients capable of taking spontaneous breaths [
         <a href="#rid11">
          11,49,50
         </a>
         ]. Higher levels of PEEP (5 to 8 cm H
         <sub>
          2
         </sub>
         O) may be beneficial for children demonstrating persistent and severe hypercarbia despite appropriate TV (6 to 10 mL/kg) and expiratory times that permit complete exhalation.
        </p>
        <p>
         We suggest setting PEEP at a minimum of 3 to 5 cm H
         <sub>
          2
         </sub>
         O initially. PEEP may be increased in increments of 1 cm H
         <sub>
          2
         </sub>
         O to determine whether additional PEEP improves ventilation. Most patients with asthma can be successfully managed with PEEP in the range of 3 to 8 cm H
         <sub>
          2
         </sub>
         O. Care must be taken to ensure that extrinsic PEEP does not exceed intrinsic or auto-PEEP. At the author's institution, PEEP is carefully titrated by senior clinicians present at the bedside assessing plateau pressures, auto-PEEP, work of breathing, and ventilator graphics (flow-time loops in particular). PEEP should be adjusted or diminished if adverse effects occur (eg, dynamic hyperinflation). (See
         <a class="local">
          'Inspiratory and expiratory times and inspiratory flow'
         </a>
         above and
         <a class="local">
          'Dynamic hyperinflation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H344205345">
         <span class="h2">
          Monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mechanically ventilated patients may require arterial and central venous access for hemodynamic monitoring, in addition to standard cardiorespiratory monitoring. Of the graphics available on most modern ventilators, the flow time curve is one parameter that allows for relatively easy assessment of air trapping. If the patient has sufficient time to exhale, the expiratory flow should to return to zero before the next breath begins  (
         <a class="graphic graphic_figure graphicRef118005" href="/z/d/graphic/118005.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Monitoring'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344205363">
         <span class="h2">
          Delivery of inhaled medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a variety of ventilator-compatible nebulization systems that allow for the continuous delivery of inhaled bronchodilators through the ventilator circuit. However, intravenous administration of bronchodilator therapy is probably a more reliable delivery route than inhalation in patients who present in extremis or who come to require noninvasive or invasive mechanical ventilation [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344205485">
         <span class="h1">
          ADJUNCTIVE THERAPIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         In extreme cases, airflow obstruction is so severe that sufficient ventilation cannot be achieved despite intensive bronchodilator therapy, intravenous glucocorticoids, ventilatory support, sedation, and paralysis. In such cases, adjunctive therapies, such as inhalational anesthetics or extracorporeal membrane oxygenation (ECMO), may be successful as rescue measures. However, the routine use of these therapies cannot be recommended on the basis of existing clinical studies. They remain heroic rescue maneuvers for the extremely refractory patient.
        </p>
        <p class="headingAnchor" id="H344205506">
         <span class="h2">
          Inhalational anesthetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         The inhalational anesthetics, halothane,
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         , and
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         , are potent bronchodilators. The positive effects of isoflurane for status asthmaticus have been described in a few case series [
         <a href="#rid52">
          52-54
         </a>
         ]. The ventilator used to deliver these agents must have a scavenger system to prevent staff exposure to the anesthetic agents. Their mechanisms of action are unknown but are purported to include direct smooth muscle relaxation, reduction of vagal tone, and synergy with catecholamines. Inhalation anesthetics can generate hypotension. Delivery in some pediatric intensive care units (PICUs) may be difficult given lack of familiarity with anesthesia machines by pediatric intensivists [
         <a href="#rid52">
          52-55
         </a>
         ]. In addition, use of these agents is associated with substantially increased hospital costs. A majority of PICUs never use volatile agents [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         Practical limitations to the use of inhalational anesthetics include the abrupt return of bronchoconstriction after discontinuation and the need for delivery via an anesthesia machine with proper scavenging of anesthetic gas (to avoid the second-hand inhalation of aerosolized anesthetic by health care personnel or other patients). This usually requires the bedside presence of an anesthesiologist, who can provide guidance regarding the dose, duration, and discontinuation of inhalational anesthetic.
        </p>
        <p>
         The use of inhalational anesthetics may be tried as a rescue maneuver in children with acute severe asthma exacerbations who have continued ventilatory failure despite appropriate mechanical ventilation and aggressive medical therapy.
        </p>
        <p class="headingAnchor" id="H344205616">
         <span class="h2">
          Extracorporeal membrane oxygenation
         </span>
         <span class="headingEndMark">
          —
         </span>
         In case reports, ECMO has been used to successfully treat acute severe asthma [
         <a href="#rid56">
          56-59
         </a>
         ]. However, the use of ECMO in such patients is a heroic measure that requires the availability of an ECMO center. The use of ECMO is precluded in all but the most desperate situations.
        </p>
        <p class="headingAnchor" id="H344206148">
         <span class="h1">
          COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications can result from the asthma exacerbation itself or the treatments. Patients with an acute severe asthma exacerbation are at risk for progressive air trapping and alveolar hyperinflation, which may lead to alveolar rupture and hemodynamic compromise. Endotracheal intubation with mechanical ventilation in the child with asthma can be associated with significant morbidity including hypotension, barotrauma (including pneumothorax), and myopathy. These complications occur in 10 to 26 percent of children who are ventilated for asthma [
         <a href="#rid6">
          6,9,40,60
         </a>
         ], and more than one-half of complications occur during or immediately after intubation [
         <a href="#rid61">
          61
         </a>
         ]. Common causes of acute deterioration in intubated patients include tube displacement or malposition, tube obstruction, pneumothorax, and equipment failure [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344206382">
         <span class="h2">
          Dynamic hyperinflation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Airflow obstruction during expiration slows lung emptying and may lead to increased lung volume. Expansion of lung volume may increase airway caliber and can reduce the resistive work of breathing. However, this physiologic response becomes maladaptive in patients with severe asthma because it increases mechanical load and elastic work of breathing [
         <a href="#rid28">
          28
         </a>
         ]. Obstruction to expiratory airflow may lead to initiation of inspiration before the preceding exhalation is complete (ie, before the lung has reached the static equilibrium volume leaving lung volume above functional residual capacity [FRC]). This phenomenon is called dynamic hyperinflation  (
         <a class="graphic graphic_figure graphicRef118005" href="/z/d/graphic/118005.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
         Dynamic hyperinflation increases the magnitude of the drop in airway pressure that the patient must generate to trigger a breath, thereby increasing the patient's workload  (
         <a class="graphic graphic_figure graphicRef64640" href="/z/d/graphic/64640.html" rel="external">
          figure 2
         </a>
         ). It can also cause alveolar overdistention resulting in hypoxemia, hypotension, or alveolar rupture. Dynamic hyperinflation can occur in patients with asthma in the absence of positive pressure, but it is more common, and potentially more difficult to manage, in ventilated patients due to the use of positive pressure.
        </p>
        <p>
         There are several ways to assess for the presence of dynamic hyperinflation. These include measurement of the end inspiratory plateau pressure (Pplat), end-inspired volume (VEI) above apneic functional residual capacity, or intrinsic or auto-positive end-expiratory pressure (PEEP) [
         <a href="#rid28">
          28
         </a>
         ]. The Pplat measure is obtained by pausing ventilation briefly (0.4 seconds) at end inspiration and measuring the airway pressure. Keeping Pplat below 30 cm H
         <sub>
          2
         </sub>
         O can decrease complications. Whether this measure is valid in children is unknown. The latter two measurements have limitations and are less commonly used. (See
         <a class="medical medical_review" href="/z/d/html/570.html" rel="external">
          "Invasive mechanical ventilation in adults with acute exacerbations of asthma"
         </a>
         .)
        </p>
        <p>
         Interventions to correct air trapping include decreasing the respiratory rate (RR; functionally increasing expiratory time), increasing inspiratory flow rates (functionally decreasing the inspiratory time), and lowering the tidal volume (TV). In adults, limiting minute ventilation is the key to avoiding dynamic hyperinflation. Keeping the minute ventilation under 115/mL/kg is a recommended goal in children  (
         <a class="graphic graphic_table graphicRef77503" href="/z/d/graphic/77503.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Ventilator settings'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/570.html" rel="external">
          "Invasive mechanical ventilation in adults with acute exacerbations of asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344206701">
         <span class="h2">
          Barotrauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary barotrauma in the mechanically ventilated patient is the result of alveolar rupture and is characterized by the development of extra-alveolar air. Barotrauma occurs when the transalveolar pressure increases to a degree that disrupts the structural integrity of the alveolus. This leads to alveolar rupture and interstitial emphysema. A pneumothorax results if the interstitial emphysema dissects along perivascular sheaths into the mediastinum and then the mediastinal parietal pleura ruptures. (See
         <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">
          "Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"
         </a>
         .)
        </p>
        <p>
         Dissection of air elsewhere along fascial planes can result in pneumomediastinum, pneumoperitoneum, or subcutaneous emphysema [
         <a href="#rid64">
          64
         </a>
         ]. Other clinical manifestations of pulmonary barotrauma include bronchopleural fistula, tension pneumothorax, tension lung cysts, hyperinflation of the left lower lobe, systemic gas embolism, and subpleural air cysts [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         Pneumothorax should be suspected if the patient becomes hypoxemic and hypotensive following intubation and the hypoxemia and hypotension do not respond to fluid administration and alteration in ventilatory pattern [
         <a href="#rid5">
          5
         </a>
         ]. A chest radiograph should be performed promptly so that treatment can be provided expeditiously. Needled decompression may be required prior to radiographic confirmation if the patient has or is about to suffer cardiovascular collapse. The most experienced clinician should perform needle decompression or insertion of a chest tube for pneumothorax [
         <a href="#rid62">
          62
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16315.html" rel="external">
          "Causes of acute respiratory distress in children", section on 'Tension pneumothorax'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344206893">
         <span class="h2">
          Hypotension
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypotension is a risk in any patient who is transitioned from negative- to positive-pressure ventilation. This risk is increased in patients with asthma who are mechanically ventilated. The hyperinflation that is intrinsic to asthma and the increased intrathoracic pressure associated with positive-pressure ventilation impede venous return to the heart. This effect may be compounded by the administration of sedatives and paralytics, which act as vasodilators and myocardial depressants. (See
         <a class="local">
          'Sedation and paralysis'
         </a>
         above.)
        </p>
        <p>
         Several steps can be taken to minimize the risk of hypotension in patients with asthma who require mechanical ventilation. These include measures to limit peak pressure and avoid hyperinflation, as described above. Patients also may benefit from the administration of intravenous fluids to improve and optimize intravascular volume. Optimization of intravascular volume may help to blunt the tachycardia that results from vasodilation associated with systemic absorption of bronchodilators. (See
         <a class="local">
          'Dynamic hyperinflation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Fluid support'
         </a>
         .)
        </p>
        <p>
         Clinicians caring for children with acute severe asthma exacerbation who require mechanical ventilation may opt to give empiric fluid administration before intubating or make fluid boluses immediately available prior to sedation in anticipation of the hypotension that may be generated by sedative administration or the conversion to positive pressure ventilation. An extreme measure that can be taken if blood pressure fails to respond to volume resuscitation is to transiently disconnect the patient from the ventilator or manual resuscitator (bag valve mask or Ambu bag). This permits complete evacuation of the lung and, in turn, appropriate venous return to the heart. (See
         <a class="medical medical_review" href="/z/d/html/6389.html" rel="external">
          "Hypovolemic shock in children in resource-abundant settings: Initial evaluation and management", section on 'Fluid resuscitation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344206965">
         <span class="h2">
          Other complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other complications seen in children with severe asthma exacerbations managed in the intensive care unit (ICU), particularly those who require mechanical ventilation, include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nosocomial infection (eg, ventilator-associated pneumonia [VAP], pneumonitis, sinusitis, tracheobronchitis, central line-associated blood stream infection [CLABSI])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal bleeding (see
         <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">
          "Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myopathy and prolonged weakness; the risk increases with neuromuscular blockade and glucocorticoid use [
         <a href="#rid29">
          29-34
         </a>
         ] (see
         <a class="local">
          'Sedation and paralysis'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subglottic stenosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aspiration at the time of intubation
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H344207165">
         <span class="h2">
          Outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mechanical ventilation is associated with increased morbidity and resource utilization in children with acute severe asthma exacerbations.
        </p>
        <p>
         In a population-based study using the largest all-payer hospital discharge database in the United States (Nationwide Inpatient Sample, 2009 to 2010), mechanical ventilation was infrequently required by children admitted to hospitals for status asthmaticus (0.55 percent incidence) but was associated with higher mortality rate and increased resource utilization [
         <a href="#rid9">
          9
         </a>
         ]. Over the study period, an overall in-hospital mortality rate of 0.03 percent was seen among over 250,000 children and adolescents admitted for status asthmaticus, but a mortality rate of 4 percent was found among children receiving mechanical ventilation. In a separate study that reviewed asthma management in 1528 children who were treated in 11 pediatric ICUs (PICUs), the mortality rate for ventilated asthmatic children was 2 to 3 percent [
         <a href="#rid5">
          5
         </a>
         ]. In a subsequent study published in 2012, reported mortality varied from 0.1 to 3 percent across pediatric centers for children admitted to the ICU [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H344207510">
         <span class="h1">
          WEANING FROM MECHANICAL VENTILATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The primary goals for mechanical ventilation are to ease the patient's work of breathing and allow time for the bronchospasm and airway obstruction to improve. The majority of patients intubated prior to intensive care unit (ICU) care are extubated within a day [
         <a href="#rid6">
          6
         </a>
         ], while children who have a trial of noninvasive positive pressure ventilation (NPPV) prior to intubation in the ICU are usually ventilated for two to three days [
         <a href="#rid10">
          10,66
         </a>
         ]. Longer ventilation times are often required if the exacerbation is accompanied by pneumonia or other systemic illness. (See
         <a class="local">
          'General principles'
         </a>
         above.)
        </p>
        <p>
         Positive response to therapy is indicated by [
         <a href="#rid12">
          12
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Improvement in and normalization of arterial blood gas measurements
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decrease in the amount of peak inspiratory pressure (PIP) necessary to deliver the desired tidal volume (TV)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased wheezing in the expiratory phase of respiration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased need for supplemental oxygen (indicating improvement in ventilation/perfusion [V/Q] mismatch)
        </p>
        <p>
        </p>
        <p>
         As the clinical status improves, the patient can be permitted to breathe spontaneously [
         <a href="#rid12">
          12
         </a>
         ]. Spontaneous modes such as pressure support allow the patient to determine the inspiratory and expiratory times. (See
         <a class="local">
          'Ventilatory modes'
         </a>
         above.)
        </p>
        <p>
         A trial of extubation can be performed when the patient is comfortably achieving adequate oxygenation and effective ventilation. This is indicated by maintenance of a normal or near-normal partial pressure of carbon dioxide in arterial blood (PaCO
         <sub>
          2
         </sub>
         ) or normal pH with minimal settings (positive end-expiratory pressure [PEEP] and pressure support of 5 cm H
         <sub>
          2
         </sub>
         O each) and a peripheral capillary oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) &gt;95 percent with a fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) of ≤0.4 or less. Once the patient demonstrates readiness for extubation, sedation should be held until the patient demonstrates appropriate strength and wakefulness. Patients should be observed in the ICU for at least 24 hours following extubation to monitor for respiratory embarrassment including tachypnea, dyspnea, increased work of breathing, hypoxia, and atelectasis.
        </p>
        <p class="headingAnchor" id="H2976237039">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113453.html" rel="external">
          "Society guideline links: Asthma in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H344207740">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The decision to intubate a patient with status asthmaticus is made clinically based upon clinical findings and physiologic changes. Care must be taken to control the airway before the patient suffers a respiratory arrest or a hypoxic insult. The clinician most experienced with airway management should perform the intubation. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">
          "Technique of emergency endotracheal intubation in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Approach"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Successful mechanical ventilation in patients with asthma depends upon limiting the risk of hyperinflation and barotrauma. This requires acceptance of an initial partial pressure of carbon dioxide in arterial blood (PaCO
         <sub>
          2
         </sub>
         ) that is higher than normal with an accompanying respiratory acidosis, a strategy called "permissive hypercapnia" or "controlled hypoventilation." (See
         <a class="local">
          'Ventilation strategy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventilator settings should be adjusted as necessary to maintain adequate exhalation, as assessed by chest auscultation and measurement of arterial blood gases, and to prevent complications  (
         <a class="graphic graphic_table graphicRef77503" href="/z/d/graphic/77503.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Ventilator settings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Supportive measures that help to prevent tachypnea, breath stacking, and ventilator dyssynchrony include analgesia, sedation, and paralysis. To minimize the risk of myopathy, neuromuscular blocking agents should be discontinued as soon as is feasible. (See
         <a class="local">
          'Sedation and paralysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adjunctive therapies, such as general anesthesia or extracorporeal membrane oxygenation (ECMO), are rarely needed for patients who do not respond to aggressive pharmacologic therapy and mechanical ventilation. (See
         <a class="local">
          'Adjunctive therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complications can result from the asthma exacerbation itself or the treatments. Complications of mechanical ventilation in patients with asthma include hyperinflation, barotrauma, pneumothorax, myopathy, nosocomial infection, gastrointestinal bleeding, and subglottic stenosis. (See
         <a class="local">
          'Complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The mortality rate for ventilated children with acute severe asthma exacerbations is approximately 1 to 5 percent. (See
         <a class="local">
          'Outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma--United States, 1980-1999. MMWR Surveill Summ 2002; 51:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moorman JE, Akinbami LJ, Bailey CM, et al. National surveillance of asthma: United States, 2001-2010. Vital Health Stat 3 2012; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nievas IF, Anand KJ. Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther 2013; 18:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva Pde S, Barreto SS. Noninvasive ventilation in status asthmaticus in children: levels of evidence. Rev Bras Ter Intensiva 2015; 27:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts JS, Bratton SL, Brogan TV. Acute severe asthma: differences in therapies and outcomes among pediatric intensive care units. Crit Care Med 2002; 30:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newth CJ, Meert KL, Clark AE, et al. Fatal and near-fatal asthma in children: the critical care perspective. J Pediatr 2012; 161:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratton SL, Odetola FO, McCollegan J, et al. Regional variation in ICU care for pediatric patients with asthma. J Pediatr 2005; 147:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll CL, Smith SR, Collins MS, et al. Endotracheal intubation and pediatric status asthmaticus: site of original care affects treatment. Pediatr Crit Care Med 2007; 8:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rampa S, Allareddy V, Asad R, et al. Outcomes of invasive mechanical ventilation in children and adolescents hospitalized due to status asthmaticus in United States: a population based study. J Asthma 2015; 52:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratton SL, Newth CJ, Zuppa AF, et al. Critical care for pediatric asthma: wide care variability and challenges for study. Pediatr Crit Care Med 2012; 13:407.
          </a>
         </li>
         <li class="breakAll">
          Rotta AT. Asthma. In: Pediatric critical care, 3rd ed, Fuhrman BP, Zimmerman JJ (Eds), Mosby, Philadelphia 2006. p.589.
         </li>
         <li class="breakAll">
          Schwarz AJ, Lubinsky PS. Acute severe asthma. In: Essentials of pediatric intensive care, 2nd ed, Levin DL, Morriss FC (Eds), Churchill Livingstone, Inc, New York 1997. p.130.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wetzel RC. Pressure-support ventilation in children with severe asthma. Crit Care Med 1996; 24:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akingbola OA, Simakajornboon N, Hadley Jr EF, Hopkins RL. Noninvasive positive-pressure ventilation in pediatric status asthmaticus. Pediatr Crit Care Med 2002; 3:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004; 10:3639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burburan SM, Xisto DG, Rocco PR. Anaesthetic management in asthma. Minerva Anestesiol 2007; 73:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong JM. Propofol infusion syndrome. Am J Ther 2010; 17:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29:1417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hauser GJ, Bell KG. Prolonged propofol infusions in critically ill children: are we ready for a large controlled study?*. Pediatr Crit Care Med 2014; 15:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chidambaran V, Costandi A, D'Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs 2015; 29:543.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration. Diprivan (propofol) injectable emulsion, USP. April 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019627s066lbl.pdf (Accessed on February 12, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koriyama H, Duff JP, Guerra GG, et al. Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*. Pediatr Crit Care Med 2014; 15:e66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cornfield DN, Tegtmeyer K, Nelson MD, et al. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002; 110:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svensson ML, Lindberg L. The use of propofol sedation in a paediatric intensive care unit. Nurs Crit Care 2012; 17:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nett S, Emeriaud G, Jarvis JD, et al. Site-level variance for adverse tracheal intubation-associated events across 15 North American PICUs: a report from the national emergency airway registry for children*. Pediatr Crit Care Med 2014; 15:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buck ML. Dexmedetomidine use in pediatric intensive care and procedural sedation. J Pediatr Pharmacol Ther 2010; 15:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takasaki Y, Kido T, Semba K. Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma. J Anesth 2009; 23:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: severe asthma. Crit Care 2002; 6:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Road J, Mackie G, Jiang TX, et al. Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve 1997; 20:1587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lacomis D, Smith TW, Chad DA. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve 1993; 16:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douglass JA, Tuxen DV, Horne M, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992; 146:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barohn RJ, Jackson CE, Rogers SJ, et al. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leatherman JW, Fluegel WL, David WS, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tousignant CP, Bevan DR, Eisen AA, et al. Acute quadriparesis in an asthmatic treated with atracurium. Can J Anaesth 1995; 42:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10. 5 Near-fatal asthma. Circulation 2005; 112 (Suppl 24):139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qureshi F. Management of children with acute asthma in the emergency department. Pediatr Emerg Care 1999; 15:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bohn D, Kissoon N. Acute asthma. Pediatr Crit Care Med 2001; 2:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maxwell GM. The problem of mucus plugging in children with asthma. J Asthma 1985; 22:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox RG, Barker GA, Bohn DJ. Efficacy, results, and complications of mechanical ventilation in children with status asthmaticus. Pediatr Pulmonol 1991; 11:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picado C, Montserrat JM, Roca J, et al. Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths. Eur J Respir Dis 1983; 64:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellomo R, McLaughlin P, Tai E, Parkin G. Asthma requiring mechanical ventilation. A low morbidity approach. Chest 1994; 105:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeNicola LK, Monem GF, Gayle MO, Kissoon N. Treatment of critical status asthmaticus in children. Pediatr Clin North Am 1994; 41:1293.
          </a>
         </li>
         <li class="breakAll">
          National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). Full text available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on September 1, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarnaik AP, Daphtary KM, Meert KL, et al. Pressure-controlled ventilation in children with severe status asthmaticus. Pediatr Crit Care Med 2004; 5:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacIntyre NR. Respiratory function during pressure support ventilation. Chest 1986; 89:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shibata S, Khemani RG, Markovitz B. Patient origin is associated with duration of endotracheal intubation and PICU length of stay for children with status asthmaticus. J Intensive Care Med 2014; 29:154.
          </a>
         </li>
         <li class="breakAll">
          Venkataraman ST. Mechanical ventilation and respiratory care. In: Pediatric critical care, Fuhrman BP, Zimmerman JJ (Eds), Mosby, Philadelphia 2006. p.692.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marini JJ. Should PEEP be used in airflow obstruction? Am Rev Respir Dis 1989; 140:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mannix R, Bachur R. Status asthmaticus in children. Curr Opin Pediatr 2007; 19:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 2006; 32:927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koninckx M, Buysse C, de Hoog M. Management of status asthmaticus in children. Paediatr Respir Rev 2013; 14:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mikkelsen ME, Woo YJ, Sager JS, et al. Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus. ASAIO J 2009; 55:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll CL. Just a lot of hot air? Volatile anesthetics in children with status asthmaticus. Pediatr Crit Care Med 2013; 14:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Char DS, Ibsen LM, Ramamoorthy C, Bratton SL. Volatile anesthetic rescue therapy in children with acute asthma: innovative but costly or just costly?. Pediatr Crit Care Med 2013; 14:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shapiro MB, Kleaveland AC, Bartlett RH. Extracorporeal life support for status asthmaticus. Chest 1993; 103:1651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conrad SA, Green R, Scott LK. Near-fatal pediatric asthma managed with pumpless arteriovenous carbon dioxide removal. Crit Care Med 2007; 35:2624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zabrocki LA, Brogan TV, Statler KD, et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality. Crit Care Med 2011; 39:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stein R, Canny GJ, Bohn DJ, et al. Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics 1989; 83:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerman JL, Dellinger RP, Shah AN, Taylor RW. Endotracheal intubation and mechanical ventilation in severe asthma. Crit Care Med 1993; 21:1727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112:IV1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanch L, Bernabé F, Lucangelo U. Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients. Respir Care 2005; 50:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maunder RJ, Pierson DJ, Hudson LD. Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management. Arch Intern Med 1984; 144:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris WP, Butler BD, Tonnesen AS, Allen SJ. Continuous venous air embolism in patients receiving positive end-expiratory pressure. Am Rev Respir Dis 1993; 147:1034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maffei FA, van der Jagt EW, Powers KS, et al. Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup. Pediatrics 2004; 114:762.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 97585 Version 8.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12420904" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Surveillance for asthma--United States, 1980-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24252609" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : National surveillance of asthma: United States, 2001-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23798903" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26761478" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Noninvasive ventilation in status asthmaticus in children: levels of evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11990919" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Acute severe asthma: differences in therapies and outcomes among pediatric intensive care units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22494876" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Fatal and near-fatal asthma in children: the critical care perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16182675" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Regional variation in ICU care for pediatric patients with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17273123" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Endotracheal intubation and pediatric status asthmaticus: site of original care affects treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25295383" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Outcomes of invasive mechanical ventilation in children and adolescents hospitalized due to status asthmaticus in United States: a population based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22067984" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Critical care for pediatric asthma: wide care variability and challenges for study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22067984" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Critical care for pediatric asthma: wide care variability and challenges for study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22067984" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Critical care for pediatric asthma: wide care variability and challenges for study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8797637" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Pressure-support ventilation in children with severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12780991" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Noninvasive positive-pressure ventilation in pediatric status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15579060" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Propofol: therapeutic indications and side-effects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17115010" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Anaesthetic management in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20844346" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Propofol infusion syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12904852" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24492188" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prolonged propofol infusions in critically ill children: are we ready for a large controlled study?*.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26290263" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Propofol: a review of its role in pediatric anesthesia and sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26290263" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Propofol: a review of its role in pediatric anesthesia and sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24247365" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12456916" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Continuous propofol infusion in 142 critically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22698162" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The use of propofol sedation in a paediatric intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24691538" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Site-level variance for adverse tracheal intubation-associated events across 15 North American PICUs: a report from the national emergency airway registry for children*.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22477789" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Dexmedetomidine use in pediatric intensive care and procedural sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19234843" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11940264" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Clinical review: severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9390673" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8423836" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Acute myopathy and neuropathy in status asthmaticus: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1362636" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Myopathy in severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7910951" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8630621" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Muscle weakness in mechanically ventilated patients with severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7743575" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Acute quadriparesis in an asthmatic treated with atracurium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : 5 Near-fatal asthma
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1347446" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Asthma: a follow up statement from an international paediatric asthma consensus group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10389961" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Management of children with acute asthma in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12797875" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Acute asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4019400" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The problem of mucus plugging in children with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1758729" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Efficacy, results, and complications of mechanical ventilation in children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6832248" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8131559" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Asthma requiring mechanical ventilation. A low morbidity approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7984387" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Treatment of critical status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7984387" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Treatment of critical status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14987342" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Pressure-controlled ventilation in children with severe status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3698697" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Respiratory function during pressure support ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23753230" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Patient origin is associated with duration of endotracheal intubation and PICU length of stay for children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23753230" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Patient origin is associated with duration of endotracheal intubation and PICU length of stay for children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2665582" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Should PEEP be used in airflow obstruction?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8625622" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Occult, occult auto-PEEP in status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17505187" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16614808" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Isoflurane therapy for severe refractory status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23578933" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Management of status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19092662" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23648873" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Just a lot of hot air? Volatile anesthetics in children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23439466" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Volatile anesthetic rescue therapy in children with acute asthma: innovative but costly or just costly?.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8404080" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Extracorporeal life support for status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17901835" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Near-fatal pediatric asthma managed with pumpless arteriovenous carbon dioxide removal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20959787" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2726328" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Severe acute asthma in a pediatric intensive care unit: six years' experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8222690" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Endotracheal intubation and mechanical ventilation in severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16314375" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15636649" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6375617" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8466103" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Continuous venous air embolism in patients receiving positive end-expiratory pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15342851" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
